Medication info
Leprasole Tablet 20mg (Rabeprazole Sodium)

Leprasole Tablet 20mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Baskan Bio Pharmaceutical Co., Ltd.
Appearance
Yellow-colored round enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging x 2)
Approval status
Active

MFDS item code 201603444 · Approved 2016.06.14 · Insurance code 656204590

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Ingredients

Manufacturer
Baskan Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This drug is effective for the treatment of gastric ulcers and duodenal ulcers. It also improves erosive or ulcerative gastroesophageal reflux disease and helps relieve symptoms of gastroesophageal reflux disease. It is used for long-term maintenance treatment of gastroesophageal reflux disease and is used in combination with antibiotics for patients with gastrointestinal ulcers infected with Helicobacter pylori. Lastly, it is also utilized for the treatment of Zollinger-Ellison syndrome. It effectively treats various gastrointestinal diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, if needed, using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Precautions

This drug should not be used in certain patients. It should not be administered to those who are allergic to this drug, its components, or have a history of hypersensitivity reactions to benzimidazole derivatives. Also, patients with allergies to specific antibiotics used in combination for Helicobacter pylori eradication should not be administered this drug. It is also safe for women who are pregnant, lactating, or have underlying heart conditions or are taking antiviral medications due to potential risks. Patients with liver dysfunction, elderly patients, and those with a history of drug allergies should use this drug with special caution. This drug contains Yellow No. 4 dye, so careful administration is needed for patients allergic to this component. If skin rashes or itching occur during treatment, usage should be immediately discontinued. Regular blood tests are required as there may be changes in red or white blood cell counts. Liver function tests should also be conducted, and if abnormal signs are found, dosing should be stopped. Cardiac issues, blood pressure abnormalities, gastrointestinal symptoms, and neurological symptoms may also occur, so patients should consult with healthcare professionals if these symptoms arise. Various unusual reactions have been reported, including respiratory issues, myalgia, skin problems, visual changes, and urinary issues, so caution is necessary. Long-term use of this drug may increase the risk of fractures and lead to hypomagnesemia (low magnesium levels in the blood). In this case, magnesium supplementation may be needed, and regular blood tests are recommended. Since this drug reduces gastric acid secretion, it may increase the risk of bacterial infections in the gastrointestinal tract; patients should inform their healthcare provider if diarrhea symptoms persist. Caution is necessary when driving or operating machinery as drowsiness may occur. This drug may interact with certain medications, so patients must inform their healthcare provider if they are taking other medications, especially antibiotics, antivirals, or anticoagulants. Pregnant or lactating women should not use this drug, and safety in children has not been established. This drug should be swallowed whole without chewing or crushing and stored out of the reach of children. Any unusual symptoms occurring during treatment should be immediately reported to a physician for necessary testing.

Side effects

Rash, hives, itching, decrease in red blood cells, decrease in white blood cells, increase in white blood cells, increase in eosinophils, increase in neutrophils, decrease in lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, increase in ALT, increase in AST, increase in ALP, increase in γ-GTP, increase in LDH, increase in total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QT prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disturbances, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, neuroexcitability, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, increased circulating blood volume, muscle weakness in limbs, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, hypoventilation, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, excessive muscle tension, neuralgia, single contraction, sweating, alopecia, skin dryness, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurry vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, gynecomastia, increase in thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be kept in a tightly sealed container. It is best to store at room temperature between 1 and 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Yellow-colored round enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.